Key result
Intensive lipid-lowering therapy reduces symptoms and cardiovascular events in lower extremity arterial disease.
Why the study?
Does lipid-lowering therapy improve limb and cardiovascular outcomes in patients with lower extremity arterial disease?
Does lipid-lowering therapy improve limb and cardiovascular outcomes in patients with lower extremity arterial disease?
Answers are grounded in this paper and cite their sources.
Intensive lipid-lowering therapy is crucial for patients with lower extremity arterial disease to reduce both limb-specific and general cardiovascular events.
INTRODUCTION: Dyslipidemia is an established risk factor for cardiovascular diseases. We aimed to review its role in the pathogenesis of lower extremity arterial disease (LEAD), as well as the effect of lipid-lowering treatment on the progression of LEAD. EVIDENCE ACQUISITION: PubMed/MedLine, EMBASE and Scopus were searched between January 1990 and January 2024 for articles investigating the role of dyslipidemias and hyperlipidemias in the pathogenesis of LEAD. A separate search focused on the effects of lipid-lowering therapy on patients with LEAD. EVIDENCE SYNTHESIS: There is evidence that dyslipidemias play a major role in the development of LEAD. All patients with LEAD should receive intensive lipid-lowering therapy for the reduction not only of claudication symptoms and amputation rates, but also of myocardial infarction and cardiovascular event rates. CONCLUSIONS: Vascular specialists should keep in mind the pivotal role of dyslipidemia in the pathogenesis and progression of LEAD.
No takes yet. Share an insight, caveat, or question.
Paraskevas et al. (2024) conducted a review in Lower extremity arterial disease (LEAD). Dyslipidemia and lipid-lowering therapy was evaluated. Dyslipidemia plays a major role in the development of lower extremity arterial disease, and intensive lipid-lowering therapy is recommended to reduce symptoms and cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: